Foster & Motley Inc Abb Vie Inc. Transaction History

Foster & Motley Inc

  • $1.58 Billion
  • Q3 2024

A detailed history of Foster & Motley Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Foster & Motley Inc holds 57,645 shares of ABBV stock, worth $10.4 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
57,645
Previous 60,804 5.2%
Holding current value
$10.4 Million
Previous $10.4 Million 9.16%
% of portfolio
0.72%
Previous 0.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$163.84 - $199.33 $517,570 - $629,683
-3,159 Reduced 5.2%
57,645 $11.4 Million
Q2 2024

Aug 02, 2024
BUY
$154.79 - $180.76 $140,858 - $164,491
910 Added 1.52%
60,804 $10.4 Million
Q1 2024

Apr 18, 2024
BUY
$159.82 - $182.1 $182,993 - $208,504
1,145 Added 1.95%
59,894 $10.9 Million
Q4 2023

Feb 01, 2024
BUY
$137.6 - $154.97 $146,819 - $165,352
1,067 Added 1.85%
58,749 $9.1 Million
Q3 2023

Oct 24, 2023
BUY
$133.59 - $154.65 $17,099 - $19,795
128 Added 0.22%
57,682 $8.6 Million
Q2 2023

Aug 08, 2023
BUY
$132.51 - $164.9 $119,921 - $149,234
905 Added 1.6%
57,554 $7.75 Million
Q1 2023

May 09, 2023
BUY
$144.61 - $166.54 $147,791 - $170,203
1,022 Added 1.84%
56,649 $9.03 Million
Q4 2022

Feb 09, 2023
SELL
$138.31 - $165.87 $12,862 - $15,425
-93 Reduced 0.17%
55,627 $8.99 Million
Q3 2022

Nov 04, 2022
BUY
$134.21 - $153.93 $113,944 - $130,686
849 Added 1.55%
55,720 $7.48 Million
Q2 2022

Aug 09, 2022
BUY
$137.62 - $174.96 $190,741 - $242,494
1,386 Added 2.59%
54,871 $8.4 Million
Q1 2022

Apr 28, 2022
BUY
$131.98 - $163.75 $135,675 - $168,335
1,028 Added 1.96%
53,485 $8.67 Million
Q4 2021

Jan 25, 2022
BUY
$107.43 - $135.93 $131,172 - $165,970
1,221 Added 2.38%
52,457 $7.1 Million
Q3 2021

Oct 29, 2021
SELL
$106.4 - $120.78 $47,454 - $53,867
-446 Reduced 0.86%
51,236 $5.53 Million
Q2 2021

Jul 20, 2021
BUY
$105.21 - $117.21 $530,889 - $591,441
5,046 Added 10.82%
51,682 $5.82 Million
Q1 2021

Apr 26, 2021
SELL
$102.3 - $112.62 $58,311 - $64,193
-570 Reduced 1.21%
46,636 $5.05 Million
Q4 2020

Feb 01, 2021
SELL
$80.49 - $108.67 $51,674 - $69,766
-642 Reduced 1.34%
47,206 $5.06 Million
Q3 2020

Oct 19, 2020
BUY
$85.91 - $100.83 $1,288 - $1,512
15 Added 0.03%
47,848 $4.19 Million
Q2 2020

Jul 20, 2020
BUY
$73.37 - $98.18 $78,579 - $105,150
1,071 Added 2.29%
47,833 $4.7 Million
Q1 2020

Apr 21, 2020
BUY
$64.5 - $97.79 $336,883 - $510,757
5,223 Added 12.57%
46,762 $3.56 Million
Q4 2019

Feb 05, 2020
SELL
$72.13 - $90.25 $64,051 - $80,142
-888 Reduced 2.09%
41,539 $3.68 Million
Q3 2019

Oct 24, 2019
SELL
$62.98 - $75.72 $108,451 - $130,389
-1,722 Reduced 3.9%
42,427 $3.21 Million
Q2 2019

Jul 17, 2019
SELL
$65.7 - $83.98 $75,423 - $96,409
-1,148 Reduced 2.53%
44,149 $3.21 Million
Q1 2019

May 08, 2019
SELL
$77.14 - $90.79 $771 - $907
-10 Reduced 0.02%
45,297 $3.65 Million
Q4 2018

Jan 30, 2019
BUY
$77.85 - $96.01 $26,235 - $32,355
337 Added 0.75%
45,307 $4.18 Million
Q3 2018

Oct 31, 2018
BUY
$88.91 - $98.84 $80,819 - $89,845
909 Added 2.06%
44,970 $4.25 Million
Q2 2018

Jul 24, 2018
BUY
$89.78 - $106.23 $282,627 - $334,412
3,148 Added 7.69%
44,061 $4.08 Million
Q1 2018

May 14, 2018
BUY
$92.01 - $123.21 $216,959 - $290,529
2,358 Added 6.12%
40,913 $3.87 Million
Q4 2017

Jan 22, 2018
SELL
$89.56 - $98.21 $48,004 - $52,640
-536 Reduced 1.37%
38,555 $3.73 Million
Q3 2017

Oct 19, 2017
BUY
$69.85 - $89.22 $2.73 Million - $3.49 Million
39,091
39,091 $3.47 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email